title: Treatment of pituitary prolactinoma reverses unresponsiveness to PDE5 inhibitor therapy in men with ED and SHPRL.
authors.forename: Tao
authors.initials: T
authors.lastname: Jiang
authors.forename: Lei
authors.initials: L
authors.lastname: Zheng
authors.forename: Xiao-Ming
authors.initials: XM
authors.lastname: Su
authors.forename: Jin-Qiang
authors.initials: JQ
authors.lastname: Peng
authors.forename: Dong-Cheng
authors.initials: DC
authors.lastname: Sun
authors.forename: Quan-Lin
authors.initials: QL
authors.lastname: Li
authors.forename: Zhi-Wei
authors.initials: ZW
authors.lastname: Zhang
authors.forename: Fa-Peng
authors.initials: FP
authors.lastname: Wang
authors.forename: Hui
authors.initials: H
authors.lastname: Jiang
mesh_terms: D000328:Adult; D007172:Erectile Dysfunction / Q000150:complications*; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications*; D008297:Male; D008875:Middle Aged; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy*; D015175:Prolactinoma / Q000150:complications / Q000188:drug therapy*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors
references.citation: J Sex Med. 2007 Sep;4(5):1485-93
references.pmid: 17655655
references.citation: Lancet. 2007 Feb 17;369(9561):597-611
references.pmid: 17307107
references.citation: N Engl J Med. 1978 Oct 19;299(16):847-52
references.pmid: 211411
references.citation: Int J Impot Res. 2005 Jul-Aug;17(4):307-19
references.pmid: 15875061
references.citation: J Sex Med. 2009 May;6(5):1457-66
references.pmid: 19210705
references.citation: Arch Esp Urol. 2010 Oct;63(8):621-7
references.pmid: 20978293
references.citation: J Sex Med. 2013 Mar;10(3):661-77
references.pmid: 22524444
references.citation: J Sex Med. 2010 Apr;7(4 Pt 2):1627-56
references.pmid: 20388162
references.citation: Indian J Med Res. 2011 Sep;134:314-9
references.pmid: 21985814